Conversion from cyclosporin (Neoral®) to tacrolimus (Prograf®) in renal allograft recipients with chronic graft nephropathy: Results of an observational study

Transplant International

Volumn 12, Issue 4, 1999, Pages 288-292

  Morris Stiff, Gareth J ^a   Baboolal, Kesh ^a   Dunstan, Frank ^a   Jurewicz, W Adam ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Chronic graft nephropathy; Cyclosporin; Tacrolimus

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DISEASE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL;

EID: 0032878529     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050226     Document Type: Article

References (14)

1. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephrology 16: 31-41
2. Curtis JJ, Dubovsky E, Welchel JD, Diethelm AG, Whelchel JD, Jones P (1986) Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 2: 477-479
3. Guijarro C, Massey ZA, Wiederkehr MR, Ma JZ, Kasiske BL (1996) Serum albumin and mortality after renal transplantation. Am J Kidney Dis 27: 117-123
4. Isoniemi HM, Krogerus L, von Willebrand E, Krogerus L, Ahonen J, Eklund B, Höcherstedt K, Salmela K, Häyry P (1992) Histopathological findings in well functioning, long-term renal allografts. Kidney Int 41: 151-160
5. Jordan ML, Naraghi R, Shapiro R, Smith D, Vivas CA, Scantlebury VP, Gritsch A, McCauley J, Randhawa P, Demetris AJ, McMichael J, Fung JJ, Starzl TE (1994) Tacrolimus rescue therapy for renal allograft rejection - five year experience. Transplantation 63: 223-228
6. McCauley J (1993) The nephrotoxicity of FK506 as compared with cyclosporin. Curr Opinion Nephrol Hypertens 2: 662-669
7. Morris-Stiff G, Ostrowski K, Balaji V, Moore R, Darby C, Lord R, Jurewicz WA (1998) Prospective randomized study comparing tacrolimus (Prograf) and cyclosporin (Neoral) as primary immunosuppression in cadaveric renal transplants: interim report of the first 80 cases. Transpl Int 11 [Suppl 1]:334-336
8. Morris-Stiff G, Talbot D, Balaji V, Baboolal K, Callanan K, Hails J, Moore R, Manas D, Lord R, Jurewicz WA (1998) Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. Transpl Int 11 [Suppl 1]:78-81
9. Opelz G, Schwarz V, Englemann A, Back D, Wilk M, Keppel E (1991) Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated patients. Transplant Proc 23: 373-37510
10. Paller MS (1990) Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation. Am J Kidney Dis 16: 414-416
11. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ (1993) The histological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporin. Am J Surg Pathol 17: 60-68
12. Schweitzer EJ, Matas AJ, Gillingham KT, Payne WD, Gores PF, Dünn DL, Sutherland DER, Najarian JS (1991) Causes of renal allograft loss. Progress in the 1980's, challenges for the 1990s. Ann Surg 214: 679-688
13. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, Randhawa P, Demetris AJ, Irish W, Mirchell S, Hakala TR, Simmons RL, Starzl TE (1995) A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 59: 485-490
14. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunhill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos LE, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Vilebrand E von, Yamaguchi Y (1993) International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422